1 / 14

A Manufacturer s Approach to Patient Assistance for People in Medicare

Our CommitmentLast year alone, AstraZeneca provided more than $407 million in savings to more than 530,000 people without drug coverage throughout the US and Puerto Rico.Within the last five years, AstraZeneca has provided over $3 billion in savings to more than 1 million patients throughout the US and Puerto Rico..

ona
Download Presentation

A Manufacturer s Approach to Patient Assistance for People in Medicare

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. A Manufacturer’s Approach to Patient Assistance for People in Medicare Tom Behan Manager, Patient Assistance Programs AstraZeneca October 26, 2007

    2. Our Commitment Last year alone, AstraZeneca provided more than $407 million in savings to more than 530,000 people without drug coverage throughout the US and Puerto Rico. Within the last five years, AstraZeneca has provided over $3 billion in savings to more than 1 million patients throughout the US and Puerto Rico. 

    3. AstraZeneca Patient Assistance Programs AZ&Me™ Prescription Savings program for people without insurance AZ&Me™ Prescription Savings for people with Medicare Part D

    4. Must: Be enrolled in Medicare Part D Be prescribed an AstraZeneca medication available in the program Have an income of less than $30,000 if an individual or less than $40,000 if a couple Have already spent at least 3% of their annual household income this year out-of-pocket on their prescription medicines

    5. ACCOLATE® (zafirlukast) ARIMIDEX® (anastrozole) ATACAND® (candesartan cilexetil) ATACAND HCT® (candesartan cilexetil-hydrochlorothiazide) CASODEX® (bicalutamide) CRESTOR® (rosuvastatin calcium) NEXIUM® (esomeprazole magnesium) PLENDIL® (felodipine) PRILOSEC® (omeprazole) PULMICORT FLEXHALER™ (budesonide inhalation powder) RHINOCORT AQUA® (budesonide) SEROQUEL® (quetiapine fumarate) SEROQUEL XR® (quetiapine fumarate) SYMBICORT ® (budesonide/formoterol fumarate dihydrate) TOPROL-XL® (metoprolol succinate) ZOMIG® (zolmitriptan) ZOMIG-ZMT ® (zolmitriptan)

    6. Program Benefits Savings are based on income, and patients pay no more than $25 for a typical 30-day AstraZeneca prescription Program offers additional savings for 60-day and 90-day prescriptions Enrollment can be done by phone or on-line Prescriptions can be filled at the local retail pharmacy Enrollment is for the calendar year then reapplication is required

More Related